Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908733-06-000015
Filing Date
2006-05-05
Accepted
2006-05-05 16:21:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS 13GA2 atherogenics.htm SC 13G/A 9459
  Complete submission text file 0000908733-06-000015.txt   11574
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Subject) CIK: 0001107601 (see all company filings)

EIN.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60563 | Film No.: 06813335
SIC: 2834 Pharmaceutical Preparations